Gilead Sciences



Ebit تغيير تاريخ
AbbVie USD 5.72B 69M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Alnylam Pharmaceuticals USD 4.89M 13.19M 2025-06
Amgen USD 2.26B 1.34B 2025-06
Biogen USD 816.6M 233.8M 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 2.26B 1.92B 2025-06
Eli Lilly USD 7.02B 3.32B 2025-06
Gilead Sciences USD 2.7B 189M 2025-06
GlaxoSmithKline GBP 2.07B 462M 2025-06
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Incyte USD 310.82M 27.18M 2025-06
J&J USD 6.94B 443M 2025-06
Merck USD 6.36B 149M 2025-06
Moderna USD -817000000 146M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD -9190000000 13.87B 2025-06
Pfizer USD 2.6B 3.33B 2025-06
PTC Therapeutics USD -34858000 1.01B 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Sanofi EUR 1.51B 1.39B 2025-06
Sarepta Therapeutics USD 115.58M 415.96M 2025-06
United Therapeutics USD 276.9M 105.9M 2025-06
Vertex Pharmaceuticals USD 1.15B 420.8M 2025-06


Gilead Sciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Aug 2025.